Funding from NIH for the GCDTR is contingent on our continued demonstration that the GCDTRis providing ‘value added’ to the conduct of type II translation in diabetes research.
If you received assistance of any kind from the GCDTR (e.g. consultation, services, materials, access to equipment or space, training, or funding), please acknowledge it in your publications and presentations using an appropriate variation of the following text:
Research reported in this publication was supported by the National Institute Of Diabetes And Digestive And Kidney Diseases of the National Institutes of Health under Award Number P30DK111024.The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Please contact us at email@example.com to allow for coordination prior to use of statement.